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A Novel Member of a Zinc Transporter Family Is Defective in
Acrodermatitis Enteropathica
Kun Wang,* Bing Zhou, Yien-Ming Kuo, Jason Zemansky, and Jane Gitschier
Howard Hughes Medical Institute and Departments of Medicine and Pediatrics, University of California, San Francisco
The rare inherited condition acrodermatitis enteropathica (AE) results from a defect in the absorption of dietary
zinc. Recently, we used homozygosity mapping in consanguineous Middle Eastern kindreds to localize the AE gene
to an ∼3.5-cM region on 8q24. In this article, we identify a gene, SLC39A4, located in the candidate region and,
in patients with AE, document mutations that likely lead to the disease. The gene encodes a histidine-rich protein,
which we refer to as “hZIP4,” which is a member of a large family of transmembrane proteins, some of which
are known to serve as zinc-uptake proteins. We show that Slc39A4 is abundantly expressed in mouse enterocytes
and that the protein resides in the apical membrane of these cells. These findings suggest that the hZIP4 transporter
is responsible for intestinal absorption of zinc.
Introduction
Zinc is an essential and versatile element, utilized by
proteins as diverse as metalloenzymes and transcrip-
tion factors. Evidence for the manifold nature of zinc
requirements comes from symptoms of nutritional zinc
deficiency, including growth retardation, immune-sys-
tem dysfunction, alopecia, severe dermatitis, diarrhea,
and, occasionally, mental disorders. These symptoms are
mirrored in a rare, autosomal recessively inherited hu-
man disease, acrodermatitis enteropathica (AE [MIM
201100]). Although AE is known to result fromdefective
intestinal absorption of zinc (Barnes and Moynahan
1973; Lombeck et al. 1975; Weismann et al. 1979; Van
den Hamer et al. 1985), the biochemical basis for this
disorder is unknown.
Previously we had mapped the AE gene to a telomeric
region of 3.5 cM on chromosome 8q24.3 (Wang et al.
2001). We now extend these studies to the discovery of
the AE gene. Our findings show that mutations in pa-
tients with AE are likely to disrupt a zinc-uptake protein
that lies on the luminal surface of the intestine.
Patients, Material, and Methods
Collection and Analysis of Material from Patients
Patients diagnosed as having AE contributed blood
samples after informed consent had been given by either
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them or their parents. Whenever possible, lymphoblas-
toid cell lines were established by Epstein-Barr virus
transformation. Clinical information for most of the pa-
tients has been presented elsewhere (Wang et al. 2001).
Genomic PCR was performed, by Platinum Taq DNA
Polymerase High Fidelity (Life Technologies), on 1 mg
of genomic DNA, with eight pairs of primers covering
all coding regions and splicing sites of the human gene,
SLC39A4 (see the HUGO Gene Nomenclature Com-
mittee Web site). Primer pairs were designed by inspec-
tion of genomic DNA sequence in GenBank (accession
number AF205589 [see the National Center for Bio-
technology Information Web site]), and these sequences
are available on request from the corresponding author.
In some areas, nesting was necessary to obtain enough
PCR product for sequencing. PCR products were run
on agarose gels, were purified by the QiaxII Gel Ex-
traction kit (Qiagen), and were sequenced with the same
primers that were used for amplification.
For Southern analysis, 20 mg of genomic DNA from
each individual was digested with restriction enzymes
overnight in a 200-ml reaction volume. Digested DNA
was precipitated with ethanol, was separated on a 0.8%
agarose gel by electrophoresis, and was transferred onto
a nylon membrane. The blot was hybridized with [32P]-
dCTP (Perkin-Elmer)–labeled probe made from human
SLC39A4 PCR products, and this was followed by
autoradiography.
For RT-PCR, total RNA was isolated from patient cell
lines by Trizol (Life Technologies), and first-strand cDNA
was obtained from 5 mg of RNA, by random hexamers
and the SuperScript First-Strand Synthesis System (Life
Technologies). First-step PCR was performed on the
cDNA, with a pair of primers at the 5′ and 3′ ends of the
SLC39A4 cDNA. Nesting PCRs were performed with
two pairs of primers, each covering half of the cDNA.
PCR products were purified as described above.
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Northern Blot Hybridization
Human multiple-tissue northern (MTN) panels I and
II and digestive-system northern blots (Clontech) were
hybridized with [32P]-dCTP–labeled probe. The probe
was generated from genomic PCR products covering ex-
ons 2, 6, and 10 of SLC39A4. Hybridization and au-
toradiography were performed according to the manu-
facturer’s instructions.
In Situ Hybridization
Colons from wild-type mice (strain C57BL/6J) were
collected, fixed overnight in 4% paraformaldehyde, em-
bedded in paraffin, and sectioned (8 mm), as described
elsewhere (Kuo et al. 1997). Radiolabeled [33P]-UTP
sense and antisense probes corresponding to a 600-bp
region of murine Slc39A4 cDNA sequence (GenBank
accession number AA396412) were hybridized to sec-
tions. Sections were subsequently washed and were ex-
posed to a photographic emulsion (Kodak NBT3) for
14 d. The slides were developed, counterstained with
toluidine blue (Sigma), and visualized by dark-field mi-
croscopy using a Nikon Eclipse E800 microscope.
Immunohistochemistry
A colon from a 6-wk-old C57Bl/6J mouse was iso-
lated, and fresh-frozen sections (8 mm)were cut and fixed
for 20min in 4% paraformaldehyde. A polyclonal rabbit
anti-mouse Zip4 antibody was raised against a 15-mer
peptide (AEETPELLNPETRRL) and was affinity puri-
fied with the peptide. The antibody was visualized by
use of a goat AlexaFluor488 anti-rabbit IgG antibody
(Molecular Probes). Nuclei were stained with 4′,6-diam-
idino-2-phenylindole, dihydrochloride (DAPI; Molecu-
lar Probes). Images were visualized, at 100# magnifi-
cation, by a Nikon Eclipse E800 microscope.
Sequence Alignments and Phylogenetic Analysis
Multiple sequence alignments were constructed with
ClustalX (Thomson et al. 1997; Jeanmougin et al. 1998).
Alignment editing and shading were performed by the
BioEdit Sequence Alignment Editor (Hall 1999). Phy-
logenetic analysis was performed by either ClustalX or
Phylip 3.6 software (Felsenstein 1989), with the neigh-
bor-joining method and (Saitou and Nei 1987) standard
parameters. Tree representations were constructed by
TreeView (Page 1996).
Results
On the basis of the map position of AE, we used GEN-
SCAN (see the The New GENSCANWeb Server at MIT
Web site; also see Burge and Karlin 1997) and the UCSC
Human Genome Browser (see the UCSC Human Ge-
nome Project Working Draft Web site) to sift through
genomic sequences from chromosome 8q24.3, for gene
discovery. Of the 140 potential genes in the 3.5-cM can-
didate-gene region, one sequence appeared promising
because it was predicted to produce a protein rich in
histidines, ligands that are hallmarks of zinc binding.
Further analysis of this candidate gene indicated that
it encodes a novel transmembrane protein, related to a
family of 1100 sequences found in mammals, flies,
worms, plants, and yeast. Figure 1 shows both the se-
quence of the predicted protein—here termed “hZIP4,”
in relation to three other human proteins (hZIP1,
hZIP2, and hZIP3), which have been shown to trans-
port zinc into the cytoplasm (Gaither and Eide 2000,
2001a, 2001b), and sequences of eight other human
proteins, whose function is unknown. The sequences
are aligned according to their relatedness, which is
shown in figure 2. All members of the protein family
share membrane topologies, including eight transmem-
brane domains and a predicted cytoplasmic loop, typ-
ically rich in histidines, located between transmembrane
domains 3 and 4 (reviewed by Guerinot [2000]). The
similarity of hZIP4 to known zinc-uptake proteinsmade
it a compelling candidate for AE.
As befits a candidate for the AE gene, expression of
the SLC39A4 gene was observed to be abundant in
small intestine, stomach, and colon, as well as in kidney
(fig. 3A). In situ hybridization to mouse colon confirmed
that the gene is expressed in the intestinal villi (fig. 3B),
and closer examination of the signals suggests that the
mRNA is expressed mostly in the mature enterocytes,
where zinc uptake has been predicted to occur (Steel
and Cousins 1985). We were not able to confirm ex-
pression in the kidney by in situ hybridization in the
mouse (data not shown). Immunohistochemistry using
an anti-mouse Zip4 antibody demonstrated that the pre-
sumed zinc-uptake protein indeed resides on the apical
surface of the enterocyte (fig. 3C).
Before determining whether defects in hZIP4 lead to
AE, we needed to define the exon/intron structure of
the SLC39A4 gene, since only genomic DNA was avail-
able from the Middle Eastern kindreds in which AE had
been mapped previously (Wang et al. 2001). By com-
parison of cDNA, EST, and genomic-sequence records,
we determined that the gene consists of 12 exons and
that two different transcripts are produced, one initi-
ating at exon 1 and splicing into exon 2 and the other
initiating upstream of exon 2. The former transcript
appears to be the more prevalent and ubiquitously ex-
pressed of these two transcripts, on the basis of EST
data, and the derived amino acid sequence of this tran-
script is presented in figure 1. Moreover, only this ver-
sion of the sequence has been observed in the murine
cDNA, EST, and genomic-sequence databases.
By direct sequence analysis of PCR-amplified
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SLC39A4 exons, we examined DNA samples from pro-
bands of six consanguineous Middle Eastern kindreds
in whom AE had been previously mapped to chromo-
some 8q24.3 (Wang et al. 2001), and we discovered
mutations in five of these kindreds. Distinct homozy-
gous missense mutations were discovered in four kin-
dreds (fig. 1 and table 1). Three of these mutations
(G330D, L372P, and G630R) lead to substitutions of
highly conserved amino acids in transmembrane do-
mains and are very likely to be the cause of disease.
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Figure 1 Sequence alignment of human ZIP4 and other human zinc transporters and related proteins. hZIP4 was used as a query to
identify all human members of the ZIP family in public databases. All resulting human sequences are aligned according to their relatedness.
Residues with 50% identity are shaded black. Putative transmembrane (TM) domains are indicated by the horizontal lines, as is the putative
signal-peptide sequence (predicted by the CBS SignalP V1.1 World Wide Web Prediction Server; also see Nielsen et al. 1997). A potential N-
glycosylation site is indicated by an asterisk (*). Locations of amino acid changes found in patients with AE are noted above the hZIP4 sequence.
Common polymorphisms, found in the process of sequencing DNA samples from patients and control subjects, include A272G (resulting in
T58A), A440G (resulting in T114A), G1169A (resulting in A357T), and C2041T (resulting in F647F). Sequence records for the proteins shown
in panel A—hZIP4 (accession number XP_035362); hLIV-1 (accession number XP_029402), in which hORF1 is derived from the nucleotide
sequence (accession number AC023500); hKE4 (accession number CAA20238); hZIP1 (accession number XP_001483); hZIP2 (accessionnumber
XP_007499); and hZIP3 (accession number AAH05869)—are available at the National Center for Biotechnology Information Web site.
None of these changes were observed either in the public
databases or in 80–100 control chromosomes from an
American population of mixed or unknown ethnicity.
However, we cannot say with certainty that the P84L
change found in Egyptian pedigree 2 leads to AE. Al-
though this substitution is the only change that we
found in this pedigree, it was also observed in 3 of 120
control chromosomes. In a fifth pedigree (pedigree 1 of
Wang et al. 2001), we found a homozygous splice-ac-
ceptor mutation in which the AG preceding exon 7 is
altered to GG. This mutation would be predicted to
cause aberrant splicing. We were unable to discover a
mutation in the remaining kindred (pedigree 9 of Wang
et al. 2001), possibly because the mutation lies either
within the exons 7–8-containing region that repeatedly
failed to amplify adequately or in an intron or regula-
tory sequence that was not surveyed. The DNA from
this proband proved to be of extremely poor quality
and was insufficient for Southern analysis.
Subsequent mutation analysis in a French patient
with no family history of consanguinity or of AE un-
covered a more complicated spectrum of SLC39A4mu-
tations. In this case, RT-PCR of SLC39A4 mRNA from
a lymphoblastoid line from the patient revealed a mis-
sense mutation (N106K). However, although only the
missense allele was apparent in the RT-PCR product,
both the missense allele and the normal allele were ob-
served in PCR of genomic DNA. Southern blot hybrid-
ization indicated, 5′ to the gene, a probable deletion of
DNA (data not shown). This finding was confirmed by
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Figure 2 Tree made by TreeView (Page 1996), demonstrating
that hZIP4 falls within the LIV-1 subfamily of the human sequences.
Table 1
SLC39A4 Missense Mutations in Patients with AE and in Control
Subjects
Patient Origin Exon
Nucleotide Change
(Amino Acid Change)
Frequency in
Control Subjects
2C Egypt 2 C351T (P84L) 3/120
1608a France 2 C418A (N106K) 0/120
1102 Egypt 6 G1089A (G330D) 0/80
303 Egypt 6 T1215C (L372P) 0/80
97025 Jordan 12 G1988C (G630R) 0/100
NOTE.—A homozygous splice acceptor mutation at exon 7 was
found in patient III1 (who was of Egyptian origin).
a Compound heterozygote for the mutation and a 2-kb upstream
deletion.
PCR and sequence analysis, identifying an ∼2-kb de-
letion of sequence located 3 kb upstream of the first
exon in one allele (data not shown). These data suggest
that the allele harboring the upstream deletion is not
expressed in the French patient.
By sequence analysis of amplified genomic DNA, we
found several additional missense mutations in patients
with AE whose families had no history of consanguinity.
One American patient of Hispanic descent was found
to be homozygous both for the P84L change described
above and for a mutation leading, at residue 309, to
substitution of a highly conserved cysteine by tyrosine.
Likewise, an Egyptian patient was found to be hetero-
zygous for the P84L substitution but had, at residue
410 in the third transmembrane domain, an additional
heterozygous amino acid change, of leucine to proline.
We cannot discern from this analysis whether the pa-
tient is a compound heterozygote for these two changes.
A heterozygous arginine-to-tryptophan substitution at
position 251 was observed in a patient from the Neth-
erlands. The implications of this substitution are hard
to assess, since the sequence in this region is unique to
hZIP4.
Discussion
We describe the discovery of a gene, SLC39A4, located
in chromosome 8q24.3, that encodes a novel member
of a protein family that includes zinc-uptake proteins.
The gene is highly expressed in the mouse enterocyte,
and the protein is localized to the apical membrane of
this cell. Eight missense mutations, one splicing defect,
and one transcription-inactivating upstream deletion
were discovered in this gene in patients with AE. Since
AE is known to map to this region (Wang et al. 2001),
and since it is a disease specifically of intestinal zinc
uptake, these findings provide both compelling evidence
that we have identified the AE gene and a molecular
basis for understanding this disorder. Unpublished evi-
dence, from our Australian colleagues, of a mutation in
the orthologous gene in Angus cattle affected with AE
further supports this discovery (I. Tammen, personal
communication).
The similarity of hZIP4 to the other zinc-uptake pro-
teins strongly implicates it in direct uptake of zinc into
the enterocyte. Zinc uptake has already been demon-
strated for hZIP1 and hZIP2 (Gaither and Eide 2000,
2001b). Although our attempts to complement a yeast
zrt1 zrt2 mutant (defective in zinc uptake) with hZIP4
failed, similar complementation experiments with
hZIP1 and hZIP2 also failed yet both proteins were
ultimately shown to transport 65Zn into mammalian
cultured cells (Gaither and Eide 2000, 2001b). Thus,
we are confident that future zinc-transport studies will
confirm the predicted role of hZIP4 in zinc uptake.
In contrast to the previously described hZIP proteins,
hZIP4 harbors a large histidine-rich N-terminal se-
quence (fig. 1). This sequence is preceded by a hydro-
phobic segment that likely serves as a signal peptide,
which is used for orienting the bulky amino-terminal
sequence into the lumen of the endoplasmic reticulum
and which then is released by cleavage (Martoglio and
Dobberstein 1998). On the basis of our localization of
murine Zip4 to the apical membrane of the enterocyte,
this hypothesis would predict a large histidine-rich do-
main dangling into the intestinal lumen, where it might
serve as a trap for dietary zinc.
Our findings foster speculation as to why zinc defi-
ciency in patients with AE can be overcome by dietary
Figure 3 Tissue distribution of SLC39A4 expression. A, Hybridization of human SLC39A4 probes to Clontech human MTN blots and
digestive-system northern blots. A 2.2-kb mRNA species was present at high levels in kidney and also in small intestine, colon, and most of the
intestinal tract. The horizontal lines indicate the position of the molecular-weight markers in each blot. B, In situ hybridization of murine Slc39A4
antisense on adult mouse colon sections, at 10# and 40# magnification. Hybridization to the antisense probe is abundant in the enterocyte,
whereas no hybridization is detected in the control (i.e., sense) probe. C, Immunohistochemical localization of mouse Zip4 to the apical membrane
of the enterocyte in mouse colon. The red arrow indicates the apical surface, and the blue staining indicates nuclei stainedwithDAPI.Only nonspecific
binding is seen with the preimmune sera. An identical result was obtained on paraffin-embedded tissue visualized with diamobenzidine (data not
shown).
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supplementation of zinc (a 2- to 20-fold excess com-
pared with the RDA). This clinical observation suggests
that patients with AE retain some mechanism for in-
testinal zinc uptake. One possibility is that the muta-
tions that we discovered in patients with AE—namely,
missense mutations, a splicing defect, and a heterozy-
gous deletion—may impede hZIP4 function but not
completely destroy it. If so, the effects of such hypo-
morphic mutations might be overcome by increased zinc
substrate. A second explanation may lie in the supple-
mental action of another zinc transporter, expressed in
the intestine. For example, the divalent metal trans-
porter DMT1 also resides on the apical surface of the
enterocyte and can transport zinc in vitro (Gunshin et
al. 1997). However, a more compelling candidate could
lie in one of the putative zinc-uptake proteins depicted
in figure 1. The sequence referred to provisionally as
“hORF1” is particularly intriguing, since SAGE (Serial
Analysis of Gene Expression [see the SAGEmap Web
site]) data demonstrate that it is expressed primarily in
the epithelium of the colon and in adenocarcinoma cells.
Indeed, we might further speculate that mutations in
this sequence could give rise to AE in patients in whom
the disease does not map to chromosome 8q24.3.
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